Evidence map›Paper›PMID 23388455›Full record

ArticleCell cycle (Georgetown, Tex.)2013

TD-60 is required for interphase cell cycle progression.

Mythili Yenjerla, Andreas Panopoulos, Caroline Reynaud, Rati Fotedar, Robert L Margolis

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Multiomic Characterization ofJCO oncology advances · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mythili YenjerlaTumor Development Program, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
Andreas Panopoulos
Caroline Reynaud
Rati Fotedar
Robert L Margolis
Sanford Burnham Prebys Medical Discovery Institute · USInserm · FRLa Jolla Alcohol Research · US

Funding

Induction of Cell Cleavage by the Mitotic SpindleR01GM068107 · NIGMS · SIDNEY KIMMEL CANCER CENTER · PI MARGOLIS, ROBERT LEWIS · 2005 to 2009
$1.8M
UV and p21 DegradationR01CA108947 · NCI · SIDNEY KIMMEL CANCER CENTER · PI FOTEDAR, RATI · 2005 to 2009
$1.7M
Induction and maintenance of mitosis by Cdk1 suppression of Protein phosphatase 1R01GM088716 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MARGOLIS, ROBERT LEWIS · 2009 to 2012
$1.5M
NCI NIH HHS R01 CA108947NCI NIH HHS R01CA108947NIGMS NIH HHS R01 GM068107NIGMS NIH HHS R01GM068107NIGMS NIH HHS R01GM08871NIGMS NIH HHS R01 GM088716
6 · The paper itself

Abstract

We previously identified TD-60 (RCC2) as a mitotic centromere-associated protein that is necessary for proper completion of mitosis. We now report that TD-60 is an essential regulator of cell cycle progression during interphase. siRNA suppression blocks progression of mammalian G₁/S phase cells and progression of G₂ cells into mitosis. Prolonged arrest occurs both in non-transformed cells and in transformed cells lacking functional p53. TD-60 associates with Rac1 and Arf6 and has recently been demonstrated to be an element of α5β1 integrin and cortactin interactomes. These associations with known elements of cell cycle control, together with our data, suggest that TD-60 is an essential component of one or more signaling pathways that drive cell cycle progression. During mitosis, TD-60 is required for correct assembly of the mitotic spindle and activation of key mitotic proteins. In contrast, in interphase TD-60 promotes cell cycle progression through what must be distinct mechanisms. TD-60 thus appears to be one of the growing categories of proteins that "moonlight," or have more than one distinct cellular function.

Indexed as

InterphaseChromosomal Proteins, Non-HistoneGene Knockdown TechniquesGuanine Nucleotide Exchange FactorsHeLa CellsHumansMitosisRNA, Small InterferingTransfectionChromosomal Proteins, Non-HistoneGuanine Nucleotide Exchange FactorsRCC2 protein, humanRNA, Small InterferingcheckpointG1 phaseG2 phasemicrotubulesRCC2

Identifiers

PMID23388455
PMCPMC3610731
OpenAlexW2045981880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.